HCW Biologics
HCWB
HCWB
14 hedge funds and large institutions have $1.5M invested in HCW Biologics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% less capital invested
Capital invested by funds: $1.5M → $1.5M (-$1.74K)
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$166K | |
| 2 | +$84.8K | |
| 3 | +$1.84K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$760 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$732 |